Search results
Japan's Takeda Pharma to restructure after annual profit slump
Reuters via Yahoo News· 13 hours agoTOKYO (Reuters) -Japan's Takeda Pharmaceutical announced a restructuring on Thursday after annual...
Microneedle Magic: New Alopecia Treatment Can Reverse Hair Loss
SciTechDaily· 13 hours agoResearchers at MIT, Brigham and Women’s Hospital, and Harvard Medical School have developed a...
The best face wash for sensitive skin in 2024 will leave your face fresh, clean and never angry
Yahoo Life Shopping· 6 days agoWhile certain skin conditions fall within the sensitive skin territory, such as eczema, rosacea and ...
Surprising Health Conditions Our Favorite Celebs Struggle With
Cheapism via AOL· 20 hours agoBruce Glikas/Getty Images CC Kim Kardashian-West Condition: Psoriasis With so much of her career...
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
GuruFocus.com via Yahoo Finance· 2 days agoThis positions JNJ-2113, a novel oral IL-23 receptor antagonist, as a potential leader in psoriasis ...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via AOL· 1 day agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 6 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
5 signs your skin is just as stressed out as you are
AOL· 6 days agoStress shows up in sneaky ways: poor sleep, irritability, and even gut issues. If you start to notice that your complexion is looking dry, red, or otherwise irritated, you may be encountering ...
Where Is Amgen Headed After the Stock Surges on Obesity Drug News?
TheStreet.com· 6 days agoThe company also "tweaked" their forward guidance and the stock was raised to a fundamental...
Many Patients With Advanced MCC Not Receiving Immunotherapy
Medscape· 4 days agoDespite improved survival rates and guideline recommendations, many eligible patients with...